4//SEC Filing
Smith Mark Alan 4
Accession 0001415889-18-001315
CIK 0001411685other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 5:21 PM ET
Size
16.8 KB
Accession
0001415889-18-001315
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−80,000→ 0 totalExercise: $3.80Exp: 2026-11-09→ Common Stock (80,000 underlying) - Award
Stock Option (Right to Buy)
2018-08-29+125,000→ 125,000 totalExercise: $1.50Exp: 2027-04-26→ Common Stock (125,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−180,000→ 0 totalExercise: $3.49Exp: 2026-06-19→ Common Stock (180,000 underlying) - Award
Stock Option (Right to Buy)
2018-08-29+80,000→ 80,000 totalExercise: $1.50Exp: 2026-11-09→ Common Stock (80,000 underlying) - Award
Stock Option (Right to Buy)
2018-08-29+180,000→ 180,000 totalExercise: $1.50Exp: 2026-06-19→ Common Stock (180,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−125,000→ 0 totalExercise: $1.96Exp: 2027-04-26→ Common Stock (125,000 underlying)
Footnotes (6)
- [F1]The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price.
- [F2]The option vests monthly over a period of four years commencing 6/19/2016.
- [F3]The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price.
- [F4]The option vests monthly over a period of three years commencing 11/9/2016.
- [F5]The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price.
- [F6]The option vests monthly over a period of three years commencing 4/26/2017.
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001677452
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 5:21 PM ET
- Size
- 16.8 KB